EOLS → $10.00 by Apr 3, 2027.

Well as the world seem to go down into chaos, I have a few names I wrote about holding up quite well, DSM-Firmenich or Grindr for example. More recently I spent time on Evolus (USD 700m market cap), a disruptor in aesthetic beauty with their botox competitor Jeuveau. They took 13% market share (\*) in the span of 5 years in the US by targeting younger consumers and being slightly more affordable. They also rode the medical spa opening growth, …